VIVEVE MEDICAL, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Revenue
Cost of revenue
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Restructuring costs
Total operating expenses
Loss from operations
Gain on forgiveness of Paycheck Protection Program loan
Modification of warrants
Interest expense, net
Other expense, net
Net loss from consolidated companies
Loss from minority interest in limited liability company
Comprehensive and net loss
Series B convertible preferred stock dividends
Net loss attributable to common stockholders
Net loss per share of common stock:
Basic and diluted (in dollars per share)
Weighted average shares used in computing net loss per common share:
Basic and diluted (in shares)

Comments